1 Huang C,Wang Y,Li X,et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China.Lancet,2020,395:497-506. 2 World Health Organization.Coronavirus disease.(COVID-19) Pandemic https://www.who.int/emergencies/diseases/novel-coronavirus-2019.Accessed 23 August,2020. 3 Chmielewska B,Barratt I,Townsend R,et al.Effects of the COVID-19 pandemic on maternal and perinatal outcomes:a systematic review and meta-analysis.Lancet Glob Health,2021,9:e759-e772. 4 Allotey J,Stallings E,Bonet M,et al.Clinical manifestations,risk factors,and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy:living systematic review and meta-analysis.BMJ,2020,370:m3320. 5 World Health Organization.DRAFT landscape of COVID-19 candidate vaccines-23 August 2022.https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.Accessed 23 August,2022. 6 World Health Organization,Strategic Advisory Group of Experts on Immunization.COVID-19 vaccines technical documents.https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization/covid-19-materials.Accessed 18 August,2022. 7 Our World in Data.Coronavirus(COVID-19) vaccinations.Accessed 24 August,2022.https://ourworldindata.org/covid-vaccinations. 8 Our World in Data.Coronavirus pandemic(COVID-19).Accessed 22 August,2022.https://ourworldindata.org/coronavirus. 9 Collie S,Champion J,Moultrie H,et al.Effectiveness of BNT162b2 vaccine against Omicron variant in South Africa.N Engl J Med,2022,386:494-496. 10 Creech CB,Anderson E,Berthaud V,et al.Evaluation of mRNA-1273 Covid-19 vaccine in children 6 to 11 years of age.N Engl J Med,2022,386:2011-2023. 11 Dai L,Gao L,Tao L,et al.Efficacy and safety of the RBD-dimer-based Covid-19 vaccine ZF2001 in adults.N Engl J Med,2022,386:2097-2111. 12 Mengistu DA,Demmu YM,Asefa YA.Global COVID-19 vaccine acceptance rate:Systematic review and meta-analysis.Front Public Health,2022,10:1044193. 13 Milad A,Marzieh PN,Hadi EGG,et al.COVID-19 vaccine acceptance among pregnant women worldwide:A systematic review and meta-analysis.PLoS One,2022,17:e0272273. 14 Wang Q,Hu S,Du F,et al.Mapping global acceptance and uptake of COVID-19 vaccination:A systematic review and meta-analysis.Commun Med(Lond),2022,2:113. 15 Galanis P,Vraka I,Siskou O,et al.Uptake of COVID-19 Vaccines among Pregnant Women:A Systematic Review and Meta-Analysis.Vaccines-Basel,2022,10:1-11. 16 Schaal NK,Zollkau J,Hepp P,et al.Pregnant and breastfeeding women's attitudes and fears regarding the COVID-19 vaccination.Arch Gynecol Obstet,2022,306:365-372. 17 World Health Organization.Guidance for the development of evidence-based vaccination recommendations 2020.https://www.who.int/immunization/sage/Guidelines_development_recommendations.pdf. 18 Collier AY,Mcmahan K,Yu J,et al.Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women.JAMA,2021,325:2370-2380. 19 Shimabukuro TT,Kim SY,Myers TR,et al.Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons.N Engl J Med,2021,384:2273-2282. 20 Zauche LH,Wallace B,Smoots AN,et al.Receipt of mRNA Covid-19 vaccines and risk of spontaneous abortion.N Engl J Med,2021,385:1533-1535. 21 Prasad S,Kalafat E,Blakeway H,et al.Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy.Nat Commun,2022,13:2414. 22 Jacob-Dolan C,Barouch DH.COVID-19 vaccines:adenoviral vectors.Annu Rev Med,2022,73:41-54. 23 Citu IM,Citu C,Gorun F,et al.Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester.Viruses,2022,14:307. 24 Magnus MC,Ortqvist AK,Dahlqwist E,et al.Association of SARS-CoV-2 Vaccination during pregnancy with pregnancy outcomes.JAMA,2022,327:1469-1477. 25 Hillson K,Clemens SC,Madhi SA,et al.Fertility rates and birth outcomes after ChAdOx1 nCoV-19(AZD1222) vaccination.Lancet,2021,398:1683-1684. 26 Halperin SA,Ye L,Mackinnon-Cameron D,et al.Final efficacy analysis,interim safety analysis,and immunogenicity of a single dose of recombinant novel coronavirus vaccine(adenovirus type 5 vector) in adults 18 years and older:an international,multicentre,randomised,double-blinded,placebo-controlled phase 3 trial.Lancet,2022,399:237-248. 27 Ruderman RS,Mormol J,Trawick E,et al.Association of COVID-19 vaccination during early pregnancy with risk of congenital fetal anomalies.JAMA Pediatr,2022,176:717-719. 28 Grana C,Ghosn L,Evrenoglou T,et al.Efficacy and safety of COVID-19 vaccines.Cochrane Database Syst Rev,2022,12:CD015477. 29 Mallory RM,Formica N,Pfeiffer S,et al.Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine(NVX-CoV2373):a secondary analysis of a randomized,placebo-controlled,phase 2 trial.Lancet Infect Dis,2022,22:1565-1576. 30 World Health Organization.The Novavax vaccine against COVID-19:What you need to know.https://www.who.int/news-room/feature-stories/detail/the-novavax-vaccine-against-covid-19-what-you-need-to-know.Accessed 28 September,2022. 31 Dunkle LM,Kotloff KL,Gay CL,et al.Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico.N Engl J Med,2022,386:531-543. 32 Glenny AT,Pope CG,Waddington H,et al.Immunological notes.XVII–XXIV.J Pathol Bacteriol,1926,29:31-40. 33 Coffman RL,Sher A,Seder RA.Vaccine adjuvants:putting innate immunity to work.Immunity,2010,33:492-503. 34 Paixao ES,Wong KLM,Alves FJO,et al.CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil:a test-negative case-control study.Bmc Med,2022,20:1-8. 35 Jeewandara C,Jayampathi KACS,Ranasinghe T,et al.Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka.PLoS Global Public Health 2022,2:e0000607. 36 Villar J,Conti C,Gunier R,et al.Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern,INTERCOVID-2022:a multinational,observational study.Lancet,2023,401:447-457. 37 Lazarus R,Querton B,Corbic I,et al.Pivotal immune-bridging study of the inactivated whole-virus COVID19 vaccine VLA2001:a phase 3,randomized controlled clinical trial in adults using adenoviral vector vaccine AZD1222 as a comparator.Available at SSRN:https://ssrn.com/abstract=4125252 or http://dx.doi.org/10.2139/ssrn.4125252. 38 Manca T,Baylis F,Munoz FM,et al.Prioritise research on vaccines for pregnant and breastfeeding women.Lancet,2022,399:890-893. 39 Juncker HG,Mulleners SJ,Ruhe EJM,et al.Comparing the human milk antibody response after vaccination with four COVID-19 vaccines:A prospective,longitudinal cohort study in the Netherlands.E Clinical Medicine,2022,47:101393. 40 Valcarce V,Stafford LS,Neu J,et al.Detection of SARS-CoV-2-Specific IgA in the human milk of COVID-19 vaccinated lactating health care workers.Breastfeed Med,2021,16:1004-1009. 41 World Health Organization.The Moderna COVID-19(mRNA-1273) vaccine:what you need to know.Accessed 18 August,2020.https://www.who.int/news-room/feature-stories/detail/the-moderna-covid-19-mrna-1273-vaccine-what-you-need-to-know. 42 World Health Organization.The Pfizer BioNTech(BNT162b2) COVID-19 vaccine:what you need to know.Accessed 18 August,2020.https://www.who.int/news-room/feature-stories/detail/who-can-take-the-pfizer-biontech-covid-19--vaccine-what-you-need-to-know. 43 中华人民共和国国家卫生健康委员会.新冠病毒疫苗接种技术指南(第一版)http://www.nhc.gov.cn/xcs/yqfkdt/202103/c2febfd04fc5498f916b1be080905771.shtml.Accessed 29 March,2021. 44 中华医学会围产医学分会.备孕,妊娠和哺乳期妇女新型冠状病毒疫苗接种的专家建议.中华围产医学杂志,2022,25:13-17. 45 A study of Ad26.COV2.S in healthy pregnant participants(COVID-19)(HORIZON 1) Accessed 25 October,2021. https://clinicaltrials.gov/ct2/show/NCT04765384. 46 United Nations.COVID-19,pregnancy and vaccine:answers to your questions.Accessed 14 September 2020.https://unric.org/en/covid-19-pregnancy-and-vaccine-answers-to-your-questions/. 47 The American College of Obstetricians and Gynecologists.COVID-19 vaccination considerations for obstetric–gynecologic care.Accessed December 2020.https://www.who.int/news-room/feature-stories/detail/who-can-take-the-pfizer-biontech-covid-19--vaccine-what-you-need-to-know. 48 Uk Health Security Agency,The Joint Committee on Vaccination and Immunisation.COVID-19 vaccination:a guide on pregnancy and breastfeeding.Accessed 11 April,2022.https://www.gov.uk/government/publications/covid-19-vaccination-women-of-childbearing-age-currently-pregnant-planning-a-pregnancy-or-breastfeeding/covid-19-vaccination-a-guide-for-women-of-childbearing-age-pregnant-planning-a-pregnancy-or-breastfeeding. 49 Royal College of Obstetricians and Gynaecologists.COVID-19 vaccines,pregnancy and breastfeeding FAQs.Accessed 13 May,2022.https://www.rcog.org.uk/guidance/coronavirus-covid-19-pregnancy-and-women-s-health/vaccination/covid-19-vaccines-pregnancy-and-breastfeeding-faqs/. 50 Goverment of Canada,The National Advisory Committee on Immunization.Vaccination and pregnancy:COVID-19.Accessed 3 May,2022.https://www.canada.ca/en/public-health/services/immunization-vaccines/vaccination-pregnancy-covid-19.html. 51 The Society of Obstetricians and Gynaecologists of Canada.COVID-19 vaccination in pregnancy——understanding the risks of COVID-19 while pregnant.https://www.pregnancyinfo.ca/covid/. 52 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.COVID-19 vaccination when pregnant or breastfeeding and for those planning pregnancy.Accessed 13 July,2022.https://ranzcog.edu.au/news/covid-19-vaccination-when-pregnant-or-breastfeeding-and-for-those-planning-pregnancy/. 53 Department of Health and Aged Care of Australia Goverment.COVID-19 vaccination-Shared decision making guide for women who are pregnant,breastfeeding or planning pregnancy.Accessed 23 August,2022.https://www.health.gov.au/resources/publications/covid-19-vaccination-shared-decision-making-guide-for-women-who-are-pregnant-breastfeeding-or-planning-pregnancy. 54 Ministry of Health.Vaccinating women who are planning a pregnancy,pregnant or breastfeeding with the COVID-19 vaccine-clarification.Accessed 28 January,2021.https://www.gov.il/en/departments/news/28012021-03.